ArticleOncoimmunology2016

Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer.

Elisa E Baracco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.